Choon-wae, Kissei conclude licensing agreement on SILODOSIN

Choong-wae Pharm said recently it has concluded a licensing agreement with Japanese company Kissei Pharmaceutical Co. Under this agreement, Choongwae will be able to exclusively distribute in Korea Silodosin, Kissei's proprietary ethical drug for the treatment of urinary problems associated with enlarged prostates.

Silodosin is a selective antagonist against the alpha 1A receptor. By blockin...